Hyderabad, India-based Dr. Reddy's Laboratories Ltd., and Prestige BioPharma Ltd., a Singapore-based firm, entered into an exclusive partnership for the supply and commercialization of the latter's proposed Trastuzumab biosimilar, in select countries. Trastuzumab (HD201) is a proposed biosimilar to Roche’s Herceptin and can be prescribed for the treatment of HER2...
India’s Bharat Biotech, Spain’s BioFabri, Partner for TB Vaccine
Hyderabad, India-based Bharat Biotech, announced a partnership with Spanish biopharmaceutical company BioFabri to develop, manufacture and distribute a new tuberculosis vaccine. MTBVAC, a live attenuated vaccine, is considered one of the most promising vaccine candidates in the current global TB vaccine pipeline. Biofabri is part of the Zendal Group based in...
Biological E Invest $234 Million to Expand Vaccine Production
Privately held Indian company, Biological E is investing $234 million in their three facilities in the Genome Valley of Hyderabad, India. The new infusion of funds will enhance the production capacity by five billion doses, increasing the cumulative capacity to about 14 billion doses per year. The company claims that...
India’s Excelra Takes Ownership in Boston-Based Anlitiks
Hyderabad India-headquartered Excelra, a global Data and Analytics provider for Life Science organizations, announced a strategic majority investment in Anlitiks, aechnology company in the value and evidence domain. This move reinforces Excelra’s footprint into the Health Economics and Outcomes Research (HEOR) and Real-World Evidence (RWE) analytics area. The deal will...
India’s Eugia Pharma Gets USFDA Approval to Make and Market Prostate Cancer Drug
Hyderabad, India-headquartered Aurobindo Pharma announced that its wholly- owned subsidiary Eugia Pharma Specialties, received final approval from the U.S. Food & Drug Administration to manufacture and market Leuprolide Acetate injection, 14 mg/2.8 mL MDV (Kit). This drug is indicated for the palliative treatment of advanced prostate cancer. The product is...
NJ-Based Amneal Pharma Launches Commercial Operations in India
Amneal Pharmaceuticals, is gearing up for new launches and is on a hiring spree. The company says it is also open for possible acquisitions to boost its India portfolio. The drug maker has plans to bring differentiated products based on novel drug delivery systems, biosimilars and specialty drugs from its...